Daniel Ecker

2.4k total citations
11 papers, 640 citations indexed

About

Daniel Ecker is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Daniel Ecker has authored 11 papers receiving a total of 640 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Neurology, 5 papers in Cellular and Molecular Neuroscience and 4 papers in Molecular Biology. Recurrent topics in Daniel Ecker's work include Neurological disorders and treatments (5 papers), Genetic Neurodegenerative Diseases (5 papers) and Mitochondrial Function and Pathology (3 papers). Daniel Ecker is often cited by papers focused on Neurological disorders and treatments (5 papers), Genetic Neurodegenerative Diseases (5 papers) and Mitochondrial Function and Pathology (3 papers). Daniel Ecker collaborates with scholars based in Germany, Denmark and United States. Daniel Ecker's co-authors include G. Bernhard Landwehrmeyer, Jan Kassubek, Freimut D. Juengling, Robert Christian Wolf, Carlos Schönfeldt‐Lecuona, Nenad Vasić, Hayrettin Tumani, Albert C. Ludolph, Sigurd D. Süßmuth and Fabio Sambataro and has published in prestigious journals such as NeuroImage, Cerebral Cortex and Experimental Neurology.

In The Last Decade

Daniel Ecker

11 papers receiving 620 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Ecker Germany 10 360 342 185 157 60 11 640
David Mozley United States 11 216 0.6× 205 0.6× 113 0.6× 136 0.9× 123 2.0× 18 657
Niels Sunde Denmark 18 624 1.7× 430 1.3× 96 0.5× 96 0.6× 75 1.3× 31 968
Adjmal Nahimi Denmark 15 623 1.7× 316 0.9× 82 0.4× 173 1.1× 75 1.3× 23 866
André R. Troiano Brazil 13 594 1.6× 283 0.8× 77 0.4× 96 0.6× 61 1.0× 25 798
Din‐E Shan Taiwan 18 553 1.5× 418 1.2× 221 1.2× 78 0.5× 32 0.5× 44 885
Valentina Nicoletti Italy 14 429 1.2× 157 0.5× 95 0.5× 87 0.6× 53 0.9× 21 717
Renán Sánchez-Porras Germany 13 238 0.7× 153 0.4× 95 0.5× 94 0.6× 64 1.1× 30 594
Claire Ewenczyk France 17 717 2.0× 356 1.0× 216 1.2× 176 1.1× 136 2.3× 31 1.0k
Annemarie Vlaar Netherlands 15 510 1.4× 200 0.6× 62 0.3× 82 0.5× 75 1.3× 26 728
S. Meftah United Kingdom 8 174 0.5× 359 1.0× 79 0.4× 83 0.5× 92 1.5× 18 662

Countries citing papers authored by Daniel Ecker

Since Specialization
Citations

This map shows the geographic impact of Daniel Ecker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Ecker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Ecker more than expected).

Fields of papers citing papers by Daniel Ecker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Ecker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Ecker. The network helps show where Daniel Ecker may publish in the future.

Co-authorship network of co-authors of Daniel Ecker

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Ecker. A scholar is included among the top collaborators of Daniel Ecker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Ecker. Daniel Ecker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Klenke, Stefanie, Andrea Engler, Daniel Ecker, et al.. (2018). TheGRK2Promoter Is Regulated by Early‐Growth Response Transcription FactorEGR‐1. Basic & Clinical Pharmacology & Toxicology. 123(6). 660–669. 8 indexed citations
2.
Musso, Francesco, Jürgen Brinkmeyer, Daniel Ecker, et al.. (2011). Ketamine effects on brain function — Simultaneous fMRI/EEG during a visual oddball task. NeuroImage. 58(2). 508–525. 66 indexed citations
3.
Ecker, Daniel, Alexander Unrath, Jan Kassubek, & Michael Sabolek. (2009). Dopamine Agonists and their risk to induce psychotic episodes in Parkinson's disease: a case-control study. BMC Neurology. 9(1). 23–23. 57 indexed citations
4.
Wolf, Robert Christian, Nenad Vasić, Carlos Schönfeldt‐Lecuona, Daniel Ecker, & G. Bernhard Landwehrmeyer. (2008). Cortical dysfunction in patients with Huntington's disease during working memory performance. Human Brain Mapping. 30(1). 327–339. 65 indexed citations
5.
Wolf, Robert Christian, Fabio Sambataro, Nenad Vasić, et al.. (2008). Aberrant connectivity of lateral prefrontal networks in presymptomatic Huntington's disease. Experimental Neurology. 213(1). 137–144. 88 indexed citations
6.
Björkqvist, Maria, Blair R. Leavitt, Jørgen E. Nielsen, et al.. (2007). Cocaine‐ and amphetamine‐regulated transcript is increased in Huntington disease. Movement Disorders. 22(13). 1952–1954. 21 indexed citations
7.
Kassubek, Jan, Freimut D. Juengling, Daniel Ecker, & G. Bernhard Landwehrmeyer. (2004). Thalamic Atrophy in Huntington's Disease Co-varies with Cognitive Performance: A Morphometric MRI Analysis. Cerebral Cortex. 15(6). 846–853. 138 indexed citations
8.
Kassubek, Jan, G. Bernhard Landwehrmeyer, Daniel Ecker, et al.. (2004). Global cerebral atrophy in early stages of Huntingtonʼs disease: quantitative MRI study. Neuroreport. 15(2). 363–365. 56 indexed citations
9.
10.
Süßmuth, Sigurd D., Hayrettin Tumani, Daniel Ecker, & Albert C. Ludolph. (2003). Amyotrophic lateral sclerosis: disease stage related changes of tau protein and S100 beta in cerebrospinal fluid and creatine kinase in serum. Neuroscience Letters. 353(1). 57–60. 80 indexed citations
11.
Herrmann, Wolfgang A., et al.. (2000). Comparison of Procalcitonin, sCD14 and Interleukin-6 Values in Septic Patients. Clinical Chemistry and Laboratory Medicine (CCLM). 38(1). 41–46. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David Mozley Breakdown of academic impact, for papers by Niels Sunde Breakdown of academic impact, for papers by Adjmal Nahimi Breakdown of academic impact, for papers by André R. Troiano Breakdown of academic impact, for papers by Din‐E Shan Breakdown of academic impact, for papers by Valentina Nicoletti Breakdown of academic impact, for papers by Renán Sánchez-Porras Breakdown of academic impact, for papers by Claire Ewenczyk Breakdown of academic impact, for papers by Annemarie Vlaar Breakdown of academic impact, for papers by S. Meftah
Rankless by CCL
2026